Primary Pulmonary Cryptococcosis Presenting as Endobronchial Tumor with Left Upper Lobe Collapse  by Chang, Ying-Shan et al.
33J Chin Med Assoc • January 2005 • Vol 68 • No 1
ORIGINAL  ARTICLE
*Correspondence to: Dr. Kuo-Chih Chou, Department of Internal Medicine, Ton-Yen General Hospital,
69 Second Hsien-Chen Road, Chupei, Hsinchu 302, Taiwan, R.O.C.
E-mail: chouwu.chou@msa.hinet.net • Received: August 11, 2003 • Accepted: June 1, 2004
CASE  REPORT
Primary pulmonary cryptococcosis is difficult to diagnose because the symptoms and radiologic findings are non-
specific. Further, pulmonary cryptococcal infections are extremely rare in individuals with normal immunity. This case
report describes a case of primary pulmonary cryptococcosis in an immunocompetent individual who presented with
left upper lobe collapse due to endobronchial occlusion. [J Chin Med Assoc 2005;68(1):33–36]
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Introduction
Cryptococcosis is an infection caused by the yeast-like
fungus Cryptococcus neoformans. The infection is
thought to be acquired by inhalation of spores into the
lungs. Patients are frequently asymptomatic and have
a tendency towards spontaneous resolution. Radio-
graphically, however, the infection may present as a
spectrum ranging from the most common findings of
a well or poorly marginated nodule or mass, and lo-
bar or segmental parenchymal opacities, to the less
common patterns of diffusely scattered nodules or
reticulonodules. This case highlights a rare instance of
primary pulmonary cryptococcosis presenting as left
upper lobe collapse due to endobronchial occlusion.
Case Report
A 33-year-old man presented with a 6-month history
of cough with chest discomfort. The patient was ini-
tially treated for upper respiratory tract infection, but
failed to improve. A consultation was therefore arranged
at the outpatient department of our hospital. Chest X-
ray revealed left upper lobe collapse (Figure 1), and the
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Figure 1. Chest X-ray (postero-anterior view) revealed left upper
lobe collapse.
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patient was subsequently admitted.
The patient, who worked as a supervisor in a glass
company, was a carrier of hepatitis B virus, but denied
any previous serious medical or surgical illness. Physical
examination was near normal, without any meninge-
al signs, and vital signs were stable. No loss of body
weight was noted. Hematologic and biologic parameters
were within normal ranges. Sputum cytology and acid-
fast stain revealed negative findings. Computed to-
mography (CT) scan of the chest revealed a suspicious
soft tissue mass in the left upper lobe bronchus and left
upper lung collapse. Bronchoscopy confirmed a whit-
ish mass over the left upper lung orifice that caused to-
tal occlusion (Figure 2). A biopsy specimen was taken
from the mass and showed cryptococcus infection
(Figure 3); serum cryptococcus antigen was positive.
Further work-ups included the following: negative
HIV test; activated third component of complement
(C3) = 106 mg/dL (normal, 90–180 mg/dL); activated
fourth component of complement (C4) = 15 mg/dL
(normal, 10–40 mg/dL); immunoglobulin G (IgG) =
1,610 mg/dL (normal, 680–1,530 mg/dL); IgA =
467 mg/dL (normal, 74.7–373.5 mg/dL); IgM =
83.7 mg/dL (normal, 40.2–167.5 mg/dL).
The patient was given oral fluconazole 200 mg
once daily for 8 weeks. However, follow-up chest X-
ray and bronchoscopy showed no improvement, so
the patient was transferred to a medical center for
lobectomy. The final biopsy report also revealed
cryptococcosis. Microscopic findings of lung pathol-
ogy from lobectomy of the left upper lobe showed
sections of lung tissue with chronic granulomatous
inflammation and multinucleate giant cells with areas
of necrosis. There were numerous cryptococci, which
appeared as small, pore-like, round-to-oval objects in
the pulmonary parenchyma and giant cells. These
microorganisms were positive for mucin and periodic
acid-Schiff stains. Hilar lymph node biopsy showed
reactive hyperplasia with no evidence of malignancy.
Discussion
The human pathogen C. neoformans is a common
soil inhabitant and may be found throughout the
world, particularly in areas where pigeon droppings
contaminate the soil.1 C. neoformans may occur as a
saprophyte on the skin or mucous membranes, although
most infections are initiated by inhalation of the
microorganism. Pulmonary infections are rare in
individuals with normal immunity, and more than 50%
of reported cases are found in immunocompromised
individuals.2
Cryptococcal infection limited to the lungs is defined
as primary pulmonary cryptococcosis, which is difficult
to diagnose because symptoms and radiologic find-
ings are non-specific, and skin tests are insufficiently
accurate. Serologic tests have an accuracy of 87% in
patients with disseminated cryptococcosis, but only
30% in patients with pulmonary masses secondary to
primary pulmonary cryptococcosis.3 Active primary
pulmonary cryptococcosis is considered if sputum
Gram stains or cultures are positive for cryptococci,
and if bilateral or multiple cavity lesions are noted
radiographically.3
Cryptococcosis is thought to result in a subpleural
focus of infection, with spreading to ipsilateral hilar
Figure 2. Bronchoscopy confirmed a whitish mass over the left
upper lung orifice that caused total occlusion.
Figure 3. Pathologic features demonstrating several small grayish
round or ovoid microorganisms (3–8 +m) in confluent rounded
spaces surrounded by pneumocysts, fibrocytes and lymphocytes
(hematoxylin & eosin, original magnification = 600).
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lymph nodes.4 Healing occurs in most cases, but dis-
semination of infection may occur in immunocom-
promised and, occasionally, in immunocompetent
individuals.4 Cryptococcosis may spread to the central
nervous system, where it most commonly presents as
meningitis. However, pulmonary infection frequently
remains subclinical,4 in which case there are no chest
X-ray abnormalities because the lung lesions have
healed.
Radiologically, primary pulmonary cryptococcosis
is typically seen as a single, well-defined mass, often
pleurally based, with multiple nodules or ill-defined
consolidation.5 The infection often mimics primary or
metastatic malignancy, or 1 or more pulmonary mass
lesions.5
Review of the literature on the radiologic mani-
festations of pulmonary cryptococcosis showed only
a few cases presenting as lung volume reduction or
collapse.6 There was only 1 report of consolidation
with minor volume loss, and radiologic evidence of
bronchial occlusion due to an intrabronchial gelati-
nous cryptococcal mass.6 A case of right middle lobe
consolidation was also reported, with an obstructive
defect later noted on spirometry, and a granuloma-
tous cryptococcal lesion within the carina, partially
obstructing both the right and left main bronchi, seen
at bronchoscopy.7 There was also a report of an ante-
rior mediastinal toruloma, compressing and infiltrat-
ing the trachea, right and left main bronchi, and adja-
cent mediastinal and hilar structures.8 Cavitation, a mil-
iary pattern, pleural effusion, and hilar or mediastinal
lymphadenopathy are also uncommon radiologic fea-
tures, mostly seen in immunocompromised patients.9
Furthermore, there is only 1 reported case of cryp-
tococcosis presenting as complete lung collapse and
mimicking pulmonary carcinoma clinically, radiogra-
phically and bronchoscopically.10 Collapse or volume
reduction is therefore an extremely rare manifestation
of pulmonary cryptococcosis. It may be secondary to
extrinsic bronchial compression or to the presence of
an intrabronchial cryptococcal mass, as in this case and
that described by Carter et al.10
A retrospective study of nine documented cases of
pulmonary cryptococcosis, with nodules or infiltrates
on chest X-ray, concluded that cryptococcal lesions
tend to be subpleural and identifiable by ultrasound,
and that diagnosis can be made by ultrasound-guided
percutaneous aspiration.11
The management of pulmonary cryptococcosis has
traditionally been based on the widely held belief that
infection resolves spontaneously in most patients,
especially immunocompetent individuals.12 However,
some patients have prominent and disabling symptoms,
and infection may occasionally spread. Some research-
ers have suggested that selected, otherwise healthy
individuals with primary pulmonary cryptococcosis,
especially patients with very prominent or disabling
symptoms, or those potentially at risk for the
development of severe disease, might benefit from
directed therapy.2,13 These researchers assert that
morbidity and mortality from pulmonary cryptococ-
cosis can be reduced if treatment is started before
dissemination and meningeal involvement occur.2,13
Nunez et al described four cases of primary pul-
monary cryptococcosis, in otherwise healthy indi-
viduals, treated with oral fluconazole 400 mg/d for
6–8 weeks.14 A literature review of other cases also
reveals that fluconazole may be an appropriate choice
of treatment for primary pulmonary cryptococcosis in
immunocompetent individuals.14 Indeed, fluconazole
is active against C. neoformans, is easily administered,
and has an excellent safety profile. However, additional
studies are needed to precisely define the role of
fluconazole in this setting and to determine the opti-
mal dosage and duration of therapy.
Cases of primary pulmonary cryptococcosis diag-
nosed non-operatively are best treated with anti-
fungal agents, such as fluconazole, and by resection of
residual disease in patients with a good prognosis.15
Thus, our case is reported to show that primary pul-
monary cryptococcosis can present clinically and
radiographically as left upper lobe collapse due to
endobronchial occlusion; treatment can be initiated
with antifungal agents such as fluconazole, and fol-
lowed by resection of residual lesions in patients with
a good prognosis.
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